MedTrace Logo

"High Levels of EMT-TFs for the Diagnosis of Colorectal Cancer (CRC)"

NCT04323813 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2020-03-27

No results posted yet for this study

Summary

The present study is aimed at detecting and measuring mRNA levels of genes involved in epithelial to mesenchymal transition (EMT) in biological samples, i.e. in peripheral blood samples of colorectal cancer (CRC) patients and healthy controls, to determine the presence of disease, its progression and risk of recurrence.

Conditions

Interventions

DIAGNOSTIC_TEST

Liquid biopsy

Detection and quantification of EMT-transcription factor mRNA levels in blood

Sponsors & Collaborators

  • Cliniche Gavazzeni spa - Bergamo (BG)

    collaborator UNKNOWN

  • Istituto Clinico Mater Domini - Castellanza (VA)

    collaborator UNKNOWN

  • Humanitas Gradenigo - Torino

    collaborator UNKNOWN

  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Luigi AG Laghi, MD, PhD · Humanitas Clinical Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2021-09-30
Completion
2022-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04323813 on ClinicalTrials.gov